06622

1.8304.19%
LF

Lit Fui Lau

President & Chief Scientific Officer

Dr. Lit Fui Lau serves as President of Zhaoke Ophthalmology Limited since April 1, 2019 and served as its Chief Operating Officer since April 1, 2019. Dr. Lau serves as Chief Scientific Officer at Zhaoke Ophthalmology Limited since January 18, 2022. Dr. Lau joined Zhaoke Ophthalmology in June 2016. Dr. Lau has many years of extensive experience in operation management and research and development of new drugs. From August 1998 to January 2008, he worked in the global research and development department of Pfizer Inc., a worldwide leading pharmaceutical company, where his last position was senior principal scientist heading a biology laboratory and supervising technicians in testing drug candidates. From January 2008 to August 2012, Dr. Lau worked as the associate director of the new product and alliance development department of GlaxoSmithKline (China) R&D Co., Ltd., a science-led global healthcare company, where he was responsible for department management and research and development of new drugs treating neurodegenerative diseases. Dr. Lau joined Lee’s Pharm in October 2012 and had been managing the operation and research and development of Lee’s Pharm until April 2016. Dr. Lau obtained both his bachelor’s degree in science and master degree of philosophy from The Chinese University of Hong Kong in December 1985 and December 1987, respectively, where he was awarded the Wong Siew Chan Scholarship. In December 1993, he obtained his Ph.D. in biochemical science from the University of Connecticut in the United States. He completed his research fellowship in neuroscience at the School of Medicine of John Hopkins University in the United States in August 1998.

Positions